| 前收市價 | 2.7100 |
| 開市 | 2.7100 |
| 買盤 | 2.6800 x 200 |
| 賣出價 | 2.7500 x 200 |
| 今日波幅 | 2.6800 - 2.7400 |
| 52 週波幅 | 0.5000 - 3.2200 |
| 成交量 | |
| 平均成交量 | 2,612,735 |
| 市值 | 407.392M |
| Beta 值 (5 年，每月) | 1.71 |
| 市盈率 (最近 12 個月) | 無 |
| 每股盈利 (最近 12 個月) | -0.8000 |
| 業績公佈日 | 2024年5月09日 - 2024年5月13日 |
| 遠期股息及收益率 | 無 (無) |
| 除息日 | 無 |
| 1 年預測目標價 | 7.00 |
Insider MonkeyHeron Therapeutics, Inc. (NASDAQ:HRTX) Q4 2023 Earnings Call Transcript
Heron Therapeutics, Inc. (NASDAQ:HRTX) Q4 2023 Earnings Call Transcript March 12, 2024 Heron Therapeutics, Inc. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Thank you for standing by, and welcome to the Heron Therapeutics Fourth Quarter 2023 Conference Call. I […]
ZacksCompared to Estimates, Heron Therapeutics (HRTX) Q4 Earnings: A Look at Key Metrics
Although the revenue and EPS for Heron Therapeutics (HRTX) give a sense of how its business performed in the quarter ended December 2023, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
ZacksOncternal Therapeutics (ONCT) Reports Q4 Loss, Tops Revenue Estimates
Oncternal Therapeutics (ONCT) delivered earnings and revenue surprises of -0.65% and 74.71%, respectively, for the quarter ended December 2023. Do the numbers hold clues to what lies ahead for the stock?
